A long-term Finnish study has found that metabolic syndrome, which is similar to pre-diabetic conditions, is associated with an increased risk of mortality cardiovascular disease. Pharmacological therapy targeting metabolic syndrome may reduce this associated risk, but this has yet to be demonstrated in clinical trials.
Edit my basket
© Datamonitor 2014. All rights reserved
Terms & Conditions